-
1
-
-
0037264812
-
Metastasis suppressors alter the signal transduction of cancer cells
-
Steeg P.S. Metastasis suppressors alter the signal transduction of cancer cells. Nat. Rev. Cancer 2003, 3:55-63.
-
(2003)
Nat. Rev. Cancer
, vol.3
, pp. 55-63
-
-
Steeg, P.S.1
-
2
-
-
0027892999
-
Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody
-
Mohanam S., Sawaya R., McCutcheon I., Ali-Osman F., Boyd D., Rao J.S. Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res. 1993, 53:4143-4147.
-
(1993)
Cancer Res.
, vol.53
, pp. 4143-4147
-
-
Mohanam, S.1
Sawaya, R.2
McCutcheon, I.3
Ali-Osman, F.4
Boyd, D.5
Rao, J.S.6
-
3
-
-
0041737535
-
Molecular mechanisms of glioma invasiveness: the role of proteases
-
Rao J.S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 2003, 3:489-501.
-
(2003)
Nat. Rev. Cancer
, vol.3
, pp. 489-501
-
-
Rao, J.S.1
-
4
-
-
0026784637
-
Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness
-
Shimoyama Y., Nagafuchi A., Fujita S., Gotoh M., Takeichi M., Tsukita S., Hirohashi S. Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness. Cancer Res. 1992, 52:5770-5774.
-
(1992)
Cancer Res.
, vol.52
, pp. 5770-5774
-
-
Shimoyama, Y.1
Nagafuchi, A.2
Fujita, S.3
Gotoh, M.4
Takeichi, M.5
Tsukita, S.6
Hirohashi, S.7
-
5
-
-
0029558476
-
E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers.
-
Berx G., Cleton-Jansen A.M., Nollet F., De Leeuw W.J., van de Vijver M., Cornelisse C., van Roy F. E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 1995, 14:6107-6115.
-
(1995)
EMBO J.
, vol.14
, pp. 6107-6115
-
-
Berx, G.1
Cleton-Jansen, A.M.2
Nollet, F.3
De Leeuw, W.J.4
van de Vijver, M.5
Cornelisse, C.6
van Roy, F.7
-
6
-
-
0033079605
-
The role of the cell-adhesion molecule E-cadherin as a tumor-suppressor gene
-
Christofori G., Semb H. The role of the cell-adhesion molecule E-cadherin as a tumor-suppressor gene. Trends Biochem. Sci. 1999, 24:73-76.
-
(1999)
Trends Biochem. Sci.
, vol.24
, pp. 73-76
-
-
Christofori, G.1
Semb, H.2
-
7
-
-
0034897832
-
E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology
-
Rubin M.A., Mucci N.R., Figurski J., Fecko A., Pienta K.J., Day M.L. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Hum. Pathol. 2001, 32:690-697.
-
(2001)
Hum. Pathol.
, vol.32
, pp. 690-697
-
-
Rubin, M.A.1
Mucci, N.R.2
Figurski, J.3
Fecko, A.4
Pienta, K.J.5
Day, M.L.6
-
8
-
-
33748098541
-
E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes
-
discussion 1414
-
Ray M.E., Mehra R., Sandler H.M., Daignault S., Shah R.B. E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes. J. Urol. 2006, 176:1409-1414. discussion 1414.
-
(2006)
J. Urol.
, vol.176
, pp. 1409-1414
-
-
Ray, M.E.1
Mehra, R.2
Sandler, H.M.3
Daignault, S.4
Shah, R.B.5
-
9
-
-
0034765511
-
Histone deacetylase inhibitors as new cancer drugs
-
Marks P.A., Richon V.M., Breslow R., Rifkind R.A. Histone deacetylase inhibitors as new cancer drugs. Curr. Opin. Oncol. 2001, 13:477-483.
-
(2001)
Curr. Opin. Oncol.
, vol.13
, pp. 477-483
-
-
Marks, P.A.1
Richon, V.M.2
Breslow, R.3
Rifkind, R.A.4
-
10
-
-
0034326799
-
Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin
-
Han J.W., Ahn S.H., Park S.H., Wang S.Y., Bae G.U., Seo D.W., Kwon H.K., Hong S., Lee H.Y., Lee Y.W., Lee H.W. Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin. Cancer Res. 2000, 60:6068-6074.
-
(2000)
Cancer Res.
, vol.60
, pp. 6068-6074
-
-
Han, J.W.1
Ahn, S.H.2
Park, S.H.3
Wang, S.Y.4
Bae, G.U.5
Seo, D.W.6
Kwon, H.K.7
Hong, S.8
Lee, H.Y.9
Lee, Y.W.10
Lee, H.W.11
-
11
-
-
21244464349
-
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer.
-
Kelly W.K., O'Connor O.A., Krug L.M., Chiao J.H., Heaney M., Curley T., MacGregore-Cortelli B., Tong W., Secrist J.P., Schwartz L., Richardson S., Chu E., Olgac S., Marks P.A., Scher H., Richon V.M. Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer. J. Clin. Oncol. 2005, 23:3923-3931.
-
(2005)
J. Clin. Oncol.
, vol.23
, pp. 3923-3931
-
-
Kelly, W.K.1
O'Connor, O.A.2
Krug, L.M.3
Chiao, J.H.4
Heaney, M.5
Curley, T.6
MacGregore-Cortelli, B.7
Tong, W.8
Secrist, J.P.9
Schwartz, L.10
Richardson, S.11
Chu, E.12
Olgac, S.13
Marks, P.A.14
Scher, H.15
Richon, V.M.16
-
12
-
-
0035577768
-
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells
-
Munster P.N., Troso-Sandoval T., Rosen N., Rifkind R., Marks P.A., Richon V.M. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. Cancer Res. 2001, 61:8492-8497.
-
(2001)
Cancer Res.
, vol.61
, pp. 8492-8497
-
-
Munster, P.N.1
Troso-Sandoval, T.2
Rosen, N.3
Rifkind, R.4
Marks, P.A.5
Richon, V.M.6
-
13
-
-
0035113602
-
MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.
-
Lee B.I., Park S.H., Kim J.W., Sausville E.A., Kim H.T., Nakanishi O., Trepel J.B., Kim S.J. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells. Cancer Res. 2001, 61:931-934.
-
(2001)
Cancer Res.
, vol.61
, pp. 931-934
-
-
Lee, B.I.1
Park, S.H.2
Kim, J.W.3
Sausville, E.A.4
Kim, H.T.5
Nakanishi, O.6
Trepel, J.B.7
Kim, S.J.8
-
14
-
-
21244458052
-
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma.
-
Ryan Q.C., Headlee D., Acharya M., Sparreboom A., Trepel J.B., Ye J., Figg W.D., Hwang K., Chung E.J., Murgo A., Melillo G., Elsayed Y., Monga M., Kalnitskiy M., Zwiebel J., Sausville E.A. Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma. J. Clin. Oncol. 2005, 23:3912-3922.
-
(2005)
J. Clin. Oncol.
, vol.23
, pp. 3912-3922
-
-
Ryan, Q.C.1
Headlee, D.2
Acharya, M.3
Sparreboom, A.4
Trepel, J.B.5
Ye, J.6
Figg, W.D.7
Hwang, K.8
Chung, E.J.9
Murgo, A.10
Melillo, G.11
Elsayed, Y.12
Monga, M.13
Kalnitskiy, M.14
Zwiebel, J.15
Sausville, E.A.16
-
15
-
-
0034796871
-
A Phase I clinical, pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule
-
Carducci M.A., Gilbert J., Bowling M.K., Noe D., Eisenberger M.A., Sinibaldi V., Zabelina Y., Chen T.L., Grochow L.B., Donehower R.C. A Phase I clinical, pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule. Clin. Cancer. Res. 2001, 7:3047-3055.
-
(2001)
Clin. Cancer. Res.
, vol.7
, pp. 3047-3055
-
-
Carducci, M.A.1
Gilbert, J.2
Bowling, M.K.3
Noe, D.4
Eisenberger, M.A.5
Sinibaldi, V.6
Zabelina, Y.7
Chen, T.L.8
Grochow, L.B.9
Donehower, R.C.10
-
16
-
-
19944432566
-
A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia
-
Byrd J.C., Marcucci G., Parthun M.R., Xiao J.J., Klisovic R.B., Moran M., Lin T.S., Liu S., Sklenar A.R., Davis M.E., Lucas D.M., Fischer B., Shank R., Tejaswi S.L., Binkley P., Wright J., Chan K.K., Grever M.R. A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia. Blood 2005, 105:959-967.
-
(2005)
Blood
, vol.105
, pp. 959-967
-
-
Byrd, J.C.1
Marcucci, G.2
Parthun, M.R.3
Xiao, J.J.4
Klisovic, R.B.5
Moran, M.6
Lin, T.S.7
Liu, S.8
Sklenar, A.R.9
Davis, M.E.10
Lucas, D.M.11
Fischer, B.12
Shank, R.13
Tejaswi, S.L.14
Binkley, P.15
Wright, J.16
Chan, K.K.17
Grever, M.R.18
-
17
-
-
0035525781
-
Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report.
-
Piekarz R.L., Robey R., Sandor V., Bakke S., Wilson W.H., Dahmoush L., Kingma D.M., Turner M.L., Altemus R., Bates S.E. Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report. Blood 2001, 98:2865-2868.
-
(2001)
Blood
, vol.98
, pp. 2865-2868
-
-
Piekarz, R.L.1
Robey, R.2
Sandor, V.3
Bakke, S.4
Wilson, W.H.5
Dahmoush, L.6
Kingma, D.M.7
Turner, M.L.8
Altemus, R.9
Bates, S.E.10
-
18
-
-
34247860871
-
Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma
-
Mann B.S., Johnson J.R., He K., Sridhara R., Abraham S., Booth B.P., Verbois L., Morse D.E., Jee J.M., Pope S., Harapanhalli R.S., Dagher R., Farrell A., Justice R., Pazdur R. Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma. Clin. Cancer Res. 2007, 13:2318-2322.
-
(2007)
Clin. Cancer Res.
, vol.13
, pp. 2318-2322
-
-
Mann, B.S.1
Johnson, J.R.2
He, K.3
Sridhara, R.4
Abraham, S.5
Booth, B.P.6
Verbois, L.7
Morse, D.E.8
Jee, J.M.9
Pope, S.10
Harapanhalli, R.S.11
Dagher, R.12
Farrell, A.13
Justice, R.14
Pazdur, R.15
-
19
-
-
0032959662
-
A hemorrhagic factor (Apicidin) produced by toxic Fusarium isolates from soybean seeds
-
Park J.S., Lee K.R., Kim J.C., Lim S.H., Seo J.A., Lee Y.W. A hemorrhagic factor (Apicidin) produced by toxic Fusarium isolates from soybean seeds. Appl. Environ. Microbiol. 1999, 65:126-130.
-
(1999)
Appl. Environ. Microbiol.
, vol.65
, pp. 126-130
-
-
Park, J.S.1
Lee, K.R.2
Kim, J.C.3
Lim, S.H.4
Seo, J.A.5
Lee, Y.W.6
-
20
-
-
66349104315
-
Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region
-
Kim S.N., Kim N.H., Lee W., Seo D.W., Kim Y.K. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region. Mol. Cancer Res. 2009, 7:735-744.
-
(2009)
Mol. Cancer Res.
, vol.7
, pp. 735-744
-
-
Kim, S.N.1
Kim, N.H.2
Lee, W.3
Seo, D.W.4
Kim, Y.K.5
-
21
-
-
78649304686
-
Role of Histone Deacetylases and Their Inhibitors in Cancer Biology and Treatment
-
Beumer J.H., Tawbi H. Role of Histone Deacetylases and Their Inhibitors in Cancer Biology and Treatment. Curr. Clin. Pharmacol. 2010, 5:196-208.
-
(2010)
Curr. Clin. Pharmacol.
, vol.5
, pp. 196-208
-
-
Beumer, J.H.1
Tawbi, H.2
-
22
-
-
0141841677
-
Expression of p21(WAF1/Cip1) through Sp1 sites by histone deacetylase inhibitor apicidin requires PI 3-kinase-PKC epsilon signaling pathway
-
Kim Y.K., Han J.W., Woo Y.N., Chun J.K., Yoo J.Y., Cho E.J., Hong S., Lee H.Y., Lee Y.W., Lee H.W. Expression of p21(WAF1/Cip1) through Sp1 sites by histone deacetylase inhibitor apicidin requires PI 3-kinase-PKC epsilon signaling pathway. Oncogene 2003, 22:6023-6031.
-
(2003)
Oncogene
, vol.22
, pp. 6023-6031
-
-
Kim, Y.K.1
Han, J.W.2
Woo, Y.N.3
Chun, J.K.4
Yoo, J.Y.5
Cho, E.J.6
Hong, S.7
Lee, H.Y.8
Lee, Y.W.9
Lee, H.W.10
-
23
-
-
0000032126
-
Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase
-
Kwon H.J., Owa T., Hassig C.A., Shimada J., Schreiber S.L. Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase. Proc. Natl. Acad. Sci. USA 1998, 95:3356-3361.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 3356-3361
-
-
Kwon, H.J.1
Owa, T.2
Hassig, C.A.3
Shimada, J.4
Schreiber, S.L.5
-
24
-
-
34548715361
-
Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells
-
Wang F., Sloss C., Zhang X., Lee S.W., Cusack J.C. Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells. Cancer Res. 2007, 67:8486-8493.
-
(2007)
Cancer Res.
, vol.67
, pp. 8486-8493
-
-
Wang, F.1
Sloss, C.2
Zhang, X.3
Lee, S.W.4
Cusack, J.C.5
-
25
-
-
0034905286
-
Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas
-
Matsumura T., Makino R., Mitamura K. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Clin. Cancer Res. 2001, 7:594-599.
-
(2001)
Clin. Cancer Res.
, vol.7
, pp. 594-599
-
-
Matsumura, T.1
Makino, R.2
Mitamura, K.3
-
26
-
-
0036108620
-
Cadherin and catenin alterations in human cancer
-
Hajra K.M., Fearon E.R. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 2002, 34:255-268.
-
(2002)
Genes Chromosomes Cancer
, vol.34
, pp. 255-268
-
-
Hajra, K.M.1
Fearon, E.R.2
-
27
-
-
0035963314
-
Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene
-
Cheng C.W., Wu P.E., Yu J.C., Huang C.S., Yue C.T., Wu C.W., Shen C.Y. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 2001, 20:3814-3823.
-
(2001)
Oncogene
, vol.20
, pp. 3814-3823
-
-
Cheng, C.W.1
Wu, P.E.2
Yu, J.C.3
Huang, C.S.4
Yue, C.T.5
Wu, C.W.6
Shen, C.Y.7
-
28
-
-
0346363757
-
Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex
-
Peinado H., Ballestar E., Esteller M., Cano A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol. Cell Biol. 2004, 24:306-319.
-
(2004)
Mol. Cell Biol.
, vol.24
, pp. 306-319
-
-
Peinado, H.1
Ballestar, E.2
Esteller, M.3
Cano, A.4
-
29
-
-
0033789680
-
The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumor cells
-
Batlle E., Sancho E., Franci C., Dominguez D., Monfar M., Baulida J., Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumor cells. Nat. Cell Biol. 2000, 2:84-89.
-
(2000)
Nat. Cell Biol.
, vol.2
, pp. 84-89
-
-
Batlle, E.1
Sancho, E.2
Franci, C.3
Dominguez, D.4
Monfar, M.5
Baulida, J.6
Garcia De Herreros, A.7
-
30
-
-
0037326569
-
The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors
-
Bolos V., Peinado H., Perez-Moreno M.A., Fraga M.F., Esteller M., Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci. 2003, 116:499-511.
-
(2003)
J. Cell Sci.
, vol.116
, pp. 499-511
-
-
Bolos, V.1
Peinado, H.2
Perez-Moreno, M.A.3
Fraga, M.F.4
Esteller, M.5
Cano, A.6
-
31
-
-
0034964418
-
The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion
-
Comijn J., Berx G., Vermassen P., Verschueren K., van Grunsven L., Bruyneel E., Mareel M., Huylebroeck D., van Roy F. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell. 2001, 7:1267-1278.
-
(2001)
Mol. Cell.
, vol.7
, pp. 1267-1278
-
-
Comijn, J.1
Berx, G.2
Vermassen, P.3
Verschueren, K.4
van Grunsven, L.5
Bruyneel, E.6
Mareel, M.7
Huylebroeck, D.8
van Roy, F.9
-
32
-
-
0034601442
-
Evidence for a function of CtBP in epithelial gene regulation and anoikis
-
Grooteclaes M.L., Frisch S.M. Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 2000, 19:3823-3828.
-
(2000)
Oncogene
, vol.19
, pp. 3823-3828
-
-
Grooteclaes, M.L.1
Frisch, S.M.2
-
33
-
-
0035920152
-
A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions
-
Perez-Moreno M.A., Locascio A., Rodrigo I., Dhondt G., Portillo F., Nieto M.A., Cano A. A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J. Biol. Chem. 2001, 276:27424-27431.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 27424-27431
-
-
Perez-Moreno, M.A.1
Locascio, A.2
Rodrigo, I.3
Dhondt, G.4
Portillo, F.5
Nieto, M.A.6
Cano, A.7
-
34
-
-
0036513626
-
The snail superfamily of zinc-finger transcription factors
-
Nieto M.A. The snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell Biol. 2002, 3:155-166.
-
(2002)
Nat. Rev. Mol. Cell Biol.
, vol.3
, pp. 155-166
-
-
Nieto, M.A.1
-
35
-
-
33748639740
-
Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression of transcription of the luteinizing hormone receptor gene
-
Zhang Y., Liao M., Dufau M.L. Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression of transcription of the luteinizing hormone receptor gene. Mol. Cell Biol. 2006, 26:6748-6761.
-
(2006)
Mol. Cell Biol.
, vol.26
, pp. 6748-6761
-
-
Zhang, Y.1
Liao, M.2
Dufau, M.L.3
-
36
-
-
44649166455
-
Protein kinase C alpha-induced derepression of the human luteinizing hormone receptor gene transcription through ERK-mediated release of HDAC1/Sin3A repressor complex from Sp1 sites
-
Liao M., Zhang Y., Dufau M.L. Protein kinase C alpha-induced derepression of the human luteinizing hormone receptor gene transcription through ERK-mediated release of HDAC1/Sin3A repressor complex from Sp1 sites. Mol. Endocrinol. 2008, 22:1449-1463.
-
(2008)
Mol. Endocrinol.
, vol.22
, pp. 1449-1463
-
-
Liao, M.1
Zhang, Y.2
Dufau, M.L.3
|